Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

March 10 (Reuters) - Microsoft (MSFT.O), opens new tab filed on Tuesday a brief in support of Anthropic's lawsuit asking the court to temporarily block the U.S. Department of Defense's designation of ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Editor’s Note — March 2026: We’ve updated our story to make sure items are in stock and available, plus we added a new best overall, the Goal Zero 1500 power station, a new model we recently reviewed, ...

67% of Gen Z and 66% of millennials own AI stocks, anticipating long-term positive market impacts. Millennials are the most bullish on AI's market benefits; 73% foresee strong returns over the next ...